Brazil's Anvisa bans ads for cannabis and mushroom products, notifies Medkaya
Published 23 h ago1 sourceEvidence: Reported
Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) published bans in the Official Bulletin on four products: a cannabis oil, a counterfeit toxin, a disinfectant alcohol, and medicines containing an active ingredient linked to neurological complications. The bans are precautionary, citing health risks, but specific details on the products and the nature of the risks remain limited. This action signals regulatory tightening in Argentina's health product oversight, potentially affecting market access for affected manufacturers.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
Published 23 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 12 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 23 h ago1 sourceEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported